Chapter 7 Flashcards
What is the Philadelphia chromosome?
A chromosome generated by a gene translocation causing chronic myeloid leukaemia. It is created by reciprocal translocation of genetic material between chromosome 9 and chromosome 22, and contains a fusion gene called BCR-ABL1.
Explain Knudsons two-hit theory?
Individuals that have inherited one mutant allel presented with a disease frequency consistent with a single somatic mutation, while individuals without a mutant allele exhibited age-onset patters consistent with 2 somatic mutations.
Name all the known oncogenes (15)?
p110-alpha, EGFR, HER2 (ERBB2), B-RAF, K/N/H-RAS, MYC, BRC-ABL, IDH1&2, JAK2, KIT, MET, FLT-3
p110-alpha: Oncogene or tumour suppressor, associated with which type of neoplasia?
Oncogene, breast, prostate, colorectal, cervical, head and neck gastric and lung
MYC: Oncogene or tumour suppressor, associated with which type of neoplasia?
Oncogene, LSA, FeLV
B-RAF: Oncogene or tumour suppressor, associated with which type of neoplasia and targeted treatment therapy?
Oncogene; TCC, prostatic carcinoma vemurafenib
K-RAS: Oncogene or tumour suppressor, associated with which type of neoplasia?
Oncogene; pancreatic, lung, colorectal, endometrial, ovarian
H-RAS: Oncogene or tumour suppressor, associated with which type of neoplasia?
Oncogene; bladder
N-RAS: Oncogene or tumour suppressor, associated with which type of neoplasia?
Oncogene; lymphoma
KIT: Oncogene or tumour suppressor, associated with which type of neoplasia?
Oncogene; GIST, AML, melanoma, mast cell tumour
EGFR: Oncogene or tumour suppressor, associated with which type of neoplasia, targeted treatment therapy?
Oncogene; Feline mammary carcinoma (HER-2) AGASAC OSA (HER-2 overexpression) TCC (HER-2 overexpression) Gastric carcinoma (HER2) cetuximab
HER2: Oncogene or tumour suppressor, associated with which type of neoplasia and targeted therapy?
Oncogene; breast, gastric, ovarian, bladder; trastuzumab, lapatinib
BCR-ABL: Oncogene or tumour suppressor, associated with which type of neoplasia, targeted therapy treatment?
Oncogene; CML, ALL, AML; imatinib, dasatinib, nilotinib
IDH-1: Oncogene or tumour suppressor, associated with which type of neoplasia?
Oncogene; glioblastoma, AML
IDH-2: Oncogene or tumour suppressor, associated with which type of neoplasia?
Oncogene; glioblastoma, AML
JAK2: Oncogene or tumour suppressor, associated with which type of neoplasia? Tx options -
Oncogene; PV, MCT, Ruloxitinib, olcacitinib licences in dogs for skin tx
MET: Oncogene or tumour suppressor, associated with which type of neoplasia?
Oncogene; OSA
Felina mammary carcinoma
ACASAC
FLT-3: Oncogene or tumour suppressor, associated with which type of neoplasia?
Oncogene; AML
P53: Oncogene or tumour suppressor, associated with which type of neoplasia?
TS; SCC OSA Perianal adenoma/carcinoma Canine adenocarcinoma Stertoli cell tumour TVT
PTEN: Oncogene or tumour suppressor, associated with which type of neoplasia?
TS; OSA Melanoma HSA HS MCT
p16ink4a: Oncogene or tumour suppressor, associated with which type of neoplasia?
TS; Melanoma, pancreatic, lung, bladder, head and neck, colorectal, breast
p14arf: Oncogene or tumour suppressor, associated with which type of neoplasia?
TS; Lung, bladder, head and neck, colorectal, breast
BRCA 1&2: Oncogene or tumour suppressor, associated with which type of neoplasia?
TS; Breast and ovarian
LBK1: Oncogene or tumour suppressor, associated with which type of neoplasia?
TS; lung, GI, pancreatic, cervical, melanoma,